Pay in 4 interest-free payments of $7.02 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Peptide Calculator The Retatrutide peptide calculator is a versatile research tool built to simplify peptide math
Follow your healthcare provider's instructions
Weight Loss in Obese Adults In non-diabetic participants with obesity, dosing was directly proportional to weight reduction
NICE approved semaglutide (Wegovy) for weight management in specialist NHS weight management services in 2023 (TA875), but availability is limited to patients with: BMI 35 kg/m with at least one weight-related comorbidity, or BMI 30 kg/m with exceptional circumstances Lower BMI thresholds apply for people from some minority ethnic groups (typically 27.5 kg/m) Participation in a specialist weight management programme Treatment limited to a maximum of 2 years Access varies by region due to local integrated care board (ICB) implementation decisions and limited NHS specialist service capacity
Tirzepatide , which targets both GLP-1 and GIP receptors, achieved 20.9 to 22.5 percent over 72 weeks in SURMOUNT-1
This result is square in the middle of that range AND Eli Lilly cautioned a few months ago that these results will not show the true efficacy or final weight loss potential. So, uh
US$ 23.72
US$ 27.47
US$ 22.05
